BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 8115626)

  • 1. Contrast-enhanced echo-planar MR imaging of myocardial perfusion: preliminary study in humans.
    Edelman RR; Li W
    Radiology; 1994 Mar; 190(3):771-7. PubMed ID: 8115626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging of head and neck tumors: comparison of T1-weighted contrast-enhanced fat-suppressed images with conventional T2-weighted and fast spin-echo T2-weighted images.
    Ross MR; Schomer DF; Chappell P; Enzmann DR
    AJR Am J Roentgenol; 1994 Jul; 163(1):173-8. PubMed ID: 8010208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
    Low RN; Sigeti JS
    AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
    Mihara F; Gupta KL; Righi AM
    Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging.
    Guthrie JA; Ward J; Robinson PJ
    Radiology; 1996 Nov; 201(2):347-51. PubMed ID: 8888221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
    Peterson MS; Baron RL; Murakami T
    Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of pancreatic transplant dysfunction: value of gadopentetate dimeglumine-enhanced MR imaging.
    Fernandez MP; Bernardino ME; Neylan JF; Olson RA
    AJR Am J Roentgenol; 1991 Jun; 156(6):1171-6. PubMed ID: 2028861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging.
    Wilke N; Jerosch-Herold M; Wang Y; Huang Y; Christensen BV; Stillman AE; Ugurbil K; McDonald K; Wilson RF
    Radiology; 1997 Aug; 204(2):373-84. PubMed ID: 9240523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
    Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
    Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
    Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
    AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction.
    Dulce MC; Duerinckx AJ; Hartiala J; Caputo GR; O'Sullivan M; Cheitlin MD; Higgins CB
    AJR Am J Roentgenol; 1993 May; 160(5):963-70. PubMed ID: 8470611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging.
    Hawighorst H; Knapstein PG; Weikel W; Knopp MV; Schaeffer U; Brix G; Essig M; Hoffmann U; Zuna I; Schönberg S; van Kaick G
    Radiology; 1996 Nov; 201(2):531-9. PubMed ID: 8888254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent and recurrent hyperparathyroidism: assessment with gadopentetate dimeglumine-enhanced MR imaging.
    Seelos KC; DeMarco R; Clark OH; Higgins CB
    Radiology; 1990 Nov; 177(2):373-8. PubMed ID: 2217771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cranial tissues: appearance at gadolinium-enhanced and nonenhanced MR imaging with magnetization transfer contrast.
    Elster AD; King JC; Mathews VP; Hamilton CA
    Radiology; 1994 Feb; 190(2):541-6. PubMed ID: 8284413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion-weighted MR imaging in the upper abdomen: preliminary clinical experience in 61 patients.
    Ichikawa T; Haradome H; Hachiya J; Nitatori T; Araki T
    AJR Am J Roentgenol; 1997 Oct; 169(4):1061-6. PubMed ID: 9308465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images.
    Hricak H; Finck S; Honda G; Göranson H
    AJR Am J Roentgenol; 1992 May; 158(5):1043-50. PubMed ID: 1566664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
    Yasumoto M; Shibuya H; Takeda M; Korenaga T
    AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved contrast of enhancing brain lesions on postgadolinium, T1-weighted spin-echo images with use of magnetization transfer.
    Finelli DA; Hurst GC; Gullapali RP; Bellon EM
    Radiology; 1994 Feb; 190(2):553-9. PubMed ID: 8284415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.